GTS SECURITIES LLC
Follow13F filer, CIK 1452765, NEW YORK, NY
GTS SECURITIES LLC reported $2,242,062,867 across 1,198 holdings for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-08. Its ten largest share positions make up 29.78% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001452765-25-000012
- Period
- 2025-06-30
- Reported value
- $2.24B
- Holdings
- 1,198
- Top 10 weight
- 29.78%
- New
- 488
- Sold out
- 508
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| IWMadded | +253,258 | $54.7M |
| STNCadded | +1,233,893 | $38.1M |
| IVVadded | +61,198 | $38M |
| IJRnew | +283,015 | $30.9M |
| QQQadded | +55,848 | $30.8M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TSLAreduced | -586,478 | -$186M |
| NVDAreduced | -696,262 | -$110M |
| XLKreduced | -220,702 | -$55.9M |
| SPYreduced | -62,936 | -$38.9M |
| TLTexited | -279,264 | -$25.4M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Back to all 1,198 share positions
Sold out in Q2 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| PACBPACIFIC BIOSCIENCES CALIF IN | 12,509 | $14.8K | shares |
| MAIDEN HOLDINGS LTDMAIDEN HOLDINGS LTD | 20,368 | $11.6K | shares |
| ALLAKOS INCALLAKOS INC | 50,252 | $11.5K | shares |
| LYELL IMMUNOPHARMA INCLYELL IMMUNOPHARMA INC | 13,046 | $7.02K | shares |
| X4 PHARMACEUTICALS INCX4 PHARMACEUTICALS INC | 12,668 | $2.99K | shares |
| Curiositystream Inc W Exp …Curiositystream Inc W Exp 10/14/… | 15,968 | $415 | shares |
| HYCROFT MINING HOLDING CORPHYCROFT MINING HOLDING CORP | 101,001 | $303 | shares |
| PROTAGENIC THERAPEUTICS INCPROTAGENIC THERAPEUTICS INC | 25,300 | $202 | shares |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001452765-25-000012 | base | 2025-08-08 | acceptance time not in the bulk data set |